These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

370 related items for PubMed ID: 29373227

  • 21. Factors predicting outcome in stroke patients treated with 0.6 mg/kg alteplase: evidence from the Japan Alteplase Clinical Trial (J-ACT).
    Mori E, Minematsu K, Nakagawara J, Yamaguchi T, Japan Alteplase Clinical Trial (J-ACT) Group.
    J Stroke Cerebrovasc Dis; 2011 Nov; 20(6):517-22. PubMed ID: 20719535
    [Abstract] [Full Text] [Related]

  • 22. Efficacy of Tirofiban Administered at Different Time Points after Intravenous Thrombolytic Therapy with Alteplase in Patients with Acute Ischemic Stroke.
    Liu J, Shi Q, Sun Y, He J, Yang B, Zhang C, Guo R.
    J Stroke Cerebrovasc Dis; 2019 Apr; 28(4):1126-1132. PubMed ID: 30655038
    [Abstract] [Full Text] [Related]

  • 23. Intravenous tissue plasminogen activator for patients with minor ischemic stroke.
    Huisa BN, Raman R, Neil W, Ernstrom K, Hemmen TM.
    J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):732-6. PubMed ID: 21531576
    [Abstract] [Full Text] [Related]

  • 24. Frequency of thrombolytic therapy in patients with acute ischemic stroke and the risk of in-hospital mortality: the German Stroke Registers Study Group.
    Heuschmann PU, Berger K, Misselwitz B, Hermanek P, Leffmann C, Adelmann M, Buecker-Nott HJ, Rother J, Neundoerfer B, Kolominsky-Rabas PL, German Stroke Registers Study Group, Competence Net Stroke.
    Stroke; 2003 May; 34(5):1106-13. PubMed ID: 12663875
    [Abstract] [Full Text] [Related]

  • 25. Imaging negative stroke: diagnoses and outcomes in intravenous tissue plasminogen activator-treated patients.
    Spokoyny I, Raman R, Ernstrom K, Meyer BC, Hemmen TM.
    J Stroke Cerebrovasc Dis; 2014 May; 23(5):1046-50. PubMed ID: 24103663
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Lipid-Lowering Pretreatment and Outcome Following Intravenous Thrombolysis for Acute Ischaemic Stroke: A Post Hoc Analysis of the Enhanced Control of Hypertension and Thrombolysis Stroke Study Trial.
    Minhas JS, Wang X, Arima H, Bath PM, Billot L, Broderick JP, Donnan GA, Kim JS, Lavados PM, Lee TH, Martins SCO, Olavarría VV, Pandian JD, Pontes-Neto OM, Ricci S, Sato S, Sharma VK, Thang NH, Wang JG, Woodward M, Chalmers J, Anderson CS, Robinson TG, ENCHANTED Investigators.
    Cerebrovasc Dis; 2018 May; 45(5-6):213-220. PubMed ID: 29705803
    [Abstract] [Full Text] [Related]

  • 28. Real-World Outcomes of Acute Ischemic Stroke Treatment with Intravenous Recombinant Tissue Plasminogen Activator.
    Betts KA, Hurley D, Song J, Sajeev G, Guo J, Du EX, Paschoalin M, Wu EQ.
    J Stroke Cerebrovasc Dis; 2017 Sep; 26(9):1996-2003. PubMed ID: 28689999
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Renal impairment reduces the efficacy of thrombolytic therapy in acute ischemic stroke.
    Power A, Epstein D, Cohen D, Bathula R, Devine J, Kar A, Taube D, Duncan N, Ames D.
    Cerebrovasc Dis; 2013 Sep; 35(1):45-52. PubMed ID: 23428996
    [Abstract] [Full Text] [Related]

  • 31. Endovascular Treatment With or Without Prior Intravenous Alteplase for Acute Ischemic Stroke.
    Chalos V, LeCouffe NE, Uyttenboogaart M, Lingsma HF, Mulder MJHL, Venema E, Treurniet KM, Eshghi O, van der Worp HB, van der Lugt A, Roos YBWEM, Majoie CBLM, Dippel DWJ, Roozenbeek B, Coutinho JM, MR CLEAN Registry Investigators.
    J Am Heart Assoc; 2019 Jun 04; 8(11):e011592. PubMed ID: 31140355
    [Abstract] [Full Text] [Related]

  • 32. Low- versus Standard-Dose Intravenous Tissue-Type Plasminogen Activator for Acute Ischemic Stroke: An Updated Meta-Analysis.
    Liu H, Zheng H, Cao Y, Pan Y, Wang D, Zhang R, You S, Zhang X, Li S, Tong X, Liu CF, Wang Y.
    J Stroke Cerebrovasc Dis; 2018 Apr 04; 27(4):988-997. PubMed ID: 29224744
    [Abstract] [Full Text] [Related]

  • 33. Intravenous Thrombolysis for Acute Ischemic Stroke due to Cervical Internal Carotid Artery Occlusion.
    Yeo LL, Kong WY, Paliwal P, Teoh HL, Seet RC, Soon D, Rathakrishnan R, Ong V, Lee TH, Wong HF, Chan BP, Leow WK, Yuan C, Ting E, Gopinathan A, Tan BY, Sharma VK.
    J Stroke Cerebrovasc Dis; 2016 Oct 04; 25(10):2423-9. PubMed ID: 27344361
    [Abstract] [Full Text] [Related]

  • 34. Expanded Indication for Recombinant Tissue Plasminogen Activator from 3 to 4.5 h after Onset of Stroke in Japan.
    Miyamoto Y, Aso S, Iwagami M, Morita K, Fushimi K, Hamasaki Y, Nangaku M, Doi K, Yasunaga H.
    J Stroke Cerebrovasc Dis; 2020 Dec 04; 29(12):105341. PubMed ID: 33039772
    [Abstract] [Full Text] [Related]

  • 35. Safety and Outcomes of Intravenous tPA in Acute Ischemic Stroke Patients With Prior Stroke Within 3 Months: Findings From Get With The Guidelines-Stroke.
    Shah S, Liang L, Kosinski A, Hernandez AF, Schwamm LH, Smith EE, Fonarow GC, Bhatt DL, Feng W, Peterson ED, Xian Y.
    Circ Cardiovasc Qual Outcomes; 2020 Jan 04; 13(1):e006031. PubMed ID: 31903770
    [Abstract] [Full Text] [Related]

  • 36. Fixed Dose IV rt-PA and Clinical Outcome in Ischemic Stroke Patients With Body Weight >100 kg: Pooled Data From 3 Randomized Clinical Trials.
    Majidi S, Leon Guerrero CR, Burger KM, Sigounas D, Olan WJ, Qureshi AI.
    J Stroke Cerebrovasc Dis; 2018 Oct 04; 27(10):2843-2848. PubMed ID: 30076113
    [Abstract] [Full Text] [Related]

  • 37. Low Alberta stroke program early computed tomography score within 3 hours of onset predicts subsequent symptomatic intracranial hemorrhage in patients treated with 0.6 mg/kg Alteplase.
    Hirano T, Sasaki M, Tomura N, Ito Y, Kobayashi S, Japan Alteplase Clinical Trial Group.
    J Stroke Cerebrovasc Dis; 2012 Nov 04; 21(8):898-902. PubMed ID: 21737309
    [Abstract] [Full Text] [Related]

  • 38. Statin use and functional outcome after tissue plasminogen activator treatment in acute ischaemic stroke.
    Miedema I, Uyttenboogaart M, Koopman K, De Keyser J, Luijckx GJ.
    Cerebrovasc Dis; 2010 Feb 04; 29(3):263-7. PubMed ID: 20090317
    [Abstract] [Full Text] [Related]

  • 39. Intravenous Tissue Plasminogen Activator in Stroke Mimics.
    Ali-Ahmed F, Federspiel JJ, Liang L, Xu H, Sevilis T, Hernandez AF, Kosinski AS, Prvu Bettger J, Smith EE, Bhatt DL, Schwamm LH, Fonarow GC, Peterson ED, Xian Y.
    Circ Cardiovasc Qual Outcomes; 2019 Aug 04; 12(8):e005609. PubMed ID: 31412730
    [Abstract] [Full Text] [Related]

  • 40. Prognostic significance of smoking in patients with acute ischemic stroke within 3 months of onset.
    Kumagai N, Origasa H, Nagao T, Takekawa H, Okuhara Y, Yamaguchi T.
    J Stroke Cerebrovasc Dis; 2013 Aug 04; 22(6):792-8. PubMed ID: 22633681
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.